Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Lowe

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 27, 2008
Effect of R3487/MEM3454, a novel nicotinic alpha7 receptor partial agonist and 5-HT3 antagonist on sustained attention in ratsAmir H Rezvani, Ehsan Kholdebarin, Frederic H Brucato, et al.
Brain Research|July 4, 2012
NAAG peptidase inhibitor reduces cellular damage in a model of TBI with secondary hypoxiaJun-Feng Feng, Gene G Gurkoff, Ken C Van, et al.
Psychopharmacology|October 31, 2002
Effects of cannabinoid receptor ligands on psychosis-relevant behavior models in the ratRenee S Martin, Robert L Secchi, Eric Sung, et al.
Resuscitation Plus|May 5, 2022
The effect of a structured ECPR protocol aided by specific simulation training in a quaternary ECMO centre: A retrospective pre-post studyAndrew C Read, Stephen Morgan, Claire Reynolds, et al.
Brain : a Journal of Neurology|February 12, 2015
Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson's disease: a dose-finding studyPer Svenningsson, Carl Rosenblad, Karolina Af Edholm Arvidsson, et al.
Brain Research|April 9, 2013
NAAG peptidase inhibitor improves motor function and reduces cognitive dysfunction in a model of TBI with secondary hypoxiaGene G Gurkoff, Jun-Feng Feng, Ken C Van, et al.
International Journal of Cardiology|December 18, 2016
Extracorporeal cardiopulmonary resuscitation for refractory cardiac arrest: A multicentre experienceMark Dennis, Peter McCanny, Mario D'Souza, et al.
Annals of the New York Academy of Sciences|April 16, 2010
Therapeutics for cognitive agingDiana W Shineman, Timothy A Salthouse, Lenore J Launer, et al.
Journal of Medicinal Chemistry|September 13, 2011
Discovery of isoxazole analogues of sazetidine-A as selective α4β2-nicotinic acetylcholine receptor partial agonists for the treatment of depressionJianhua Liu, Li-Fang Yu, J Brek Eaton, et al.
Brain Research|May 14, 2011
Post-injury administration of NAAG peptidase inhibitor prodrug, PGI-02776, in experimental TBIJun-Feng Feng, Ken C Van, Gene G Gurkoff, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 27, 2008
Effect of R3487/MEM3454, a novel nicotinic alpha7 receptor partial agonist and 5-HT3 antagonist on sustained attention in ratsAmir H Rezvani, Ehsan Kholdebarin, Frederic H Brucato, et al.
Brain Research|July 4, 2012
NAAG peptidase inhibitor reduces cellular damage in a model of TBI with secondary hypoxiaJun-Feng Feng, Gene G Gurkoff, Ken C Van, et al.
Psychopharmacology|October 31, 2002
Effects of cannabinoid receptor ligands on psychosis-relevant behavior models in the ratRenee S Martin, Robert L Secchi, Eric Sung, et al.
Resuscitation Plus|May 5, 2022
The effect of a structured ECPR protocol aided by specific simulation training in a quaternary ECMO centre: A retrospective pre-post studyAndrew C Read, Stephen Morgan, Claire Reynolds, et al.
Brain : a Journal of Neurology|February 12, 2015
Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson's disease: a dose-finding studyPer Svenningsson, Carl Rosenblad, Karolina Af Edholm Arvidsson, et al.
Brain Research|April 9, 2013
NAAG peptidase inhibitor improves motor function and reduces cognitive dysfunction in a model of TBI with secondary hypoxiaGene G Gurkoff, Jun-Feng Feng, Ken C Van, et al.
International Journal of Cardiology|December 18, 2016
Extracorporeal cardiopulmonary resuscitation for refractory cardiac arrest: A multicentre experienceMark Dennis, Peter McCanny, Mario D'Souza, et al.
Annals of the New York Academy of Sciences|April 16, 2010
Therapeutics for cognitive agingDiana W Shineman, Timothy A Salthouse, Lenore J Launer, et al.
Journal of Medicinal Chemistry|September 13, 2011
Discovery of isoxazole analogues of sazetidine-A as selective α4β2-nicotinic acetylcholine receptor partial agonists for the treatment of depressionJianhua Liu, Li-Fang Yu, J Brek Eaton, et al.
Brain Research|May 14, 2011
Post-injury administration of NAAG peptidase inhibitor prodrug, PGI-02776, in experimental TBIJun-Feng Feng, Ken C Van, Gene G Gurkoff, et al.
Pageof 3